Literature DB >> 31227876

Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Cláudia Torres1,2, Rui Machado3, Margarida Lima4,5.   

Abstract

Recent findings have suggested that the primary factors for development of chronic venous disease (CVD), which commonly manifests as varicose veins (VV), are due to structural and biochemical modifications of the vessel wall. The aim of this exploratory study was to characterize by flow cytometry the endothelial cells (EC) mechanically extracted from the varicose saphenous veins (VSV) segments of patients submitted to VV surgery, and to compare the expression of cell surface molecules in these EC with that observed in the EC from the graft SV (GSV) of patients undergoing bypass surgery. EC were isolated from distal- (varicose trunk) and from proximal- (nearly normal) VSV segments of 30 patients submitted to VV surgery, and from proximal GSV segments of 20 patients submitted to bypass surgery (control group), using a mechanical method, and their immunophenotype was characterized by flow cytometry. EC were identified as being CD45negCD146brightCD31bright, and analyzed for expression of activation-related (CD54, CD62E, CD106), procoagulant (CD142), and cell junction (CD31, CD146) molecules, and for the scavenger receptor, CD36. The EC harvested from the SV segments of CVD patients had lower expression of all the molecules evaluated, in comparison to controls; these differences were more evident for the EC isolated from the distal-VSV. The EC extracted from the proximal- and distal-VSV segments of the CVD patients also differ from each other, the first having lower levels of CD62E, CD106, CD142 and CD36. Groups did not match for gender and controls were heterogeneous concerning the underlying pathologies, which may have a confounding effect. Our study revealed that the EC isolated from varicose (distal) and nearly normal (proximal) VSV segments of the CVD patients differ phenotypically from each other, and from the EC of the control group. The VSV segments more affected by the CVD have the lowest expression of the studied markers. We hypothesize that CVD is associated with a decrease on the EC surface molecules, causing EC dysfunctionality. Further studies with a large number of gender-matched participants are needed, to confirm the results obtained in this exploratory study.

Entities:  

Keywords:  Chronic venous disease; Endothelial cell markers; Endothelial cells; Flow cytometry; Saphenous veins

Year:  2019        PMID: 31227876      PMCID: PMC7152743          DOI: 10.1007/s00380-019-01451-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  97 in total

1.  Hemoptysis developing soon after use of sildenafil: an observation on two cases.

Authors:  Gokhan Yuncu; Sibel Ozkurt; Zafer Sinik; Goksel Kiter
Journal:  Asian J Androl       Date:  2006-06-05       Impact factor: 3.285

2.  Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia.

Authors:  C Michiels; T Arnould; R Thibaut-Vercruyssen; N Bouaziz; D Janssens; J Remacle
Journal:  Int Angiol       Date:  1997-06       Impact factor: 2.789

3.  Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study.

Authors:  C Badier-Commander; A Couvelard; D Henin; T Verbeuren; J B Michel; M P Jacob
Journal:  J Pathol       Date:  2001-03       Impact factor: 7.996

4.  Leukocyte activation in patients with venous insufficiency.

Authors:  S Takase; G Schmid-Schönbein; J J Bergan
Journal:  J Vasc Surg       Date:  1999-07       Impact factor: 4.268

5.  Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content.

Authors:  J P Travers; C E Brookes; J Evans; D M Baker; C Kent; G S Makin; T M Mayhew
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-02       Impact factor: 7.069

6.  Chronic venous disease in an ethnically diverse population: the San Diego Population Study.

Authors:  Michael H Criqui; Maritess Jamosmos; Arnost Fronek; Julie O Denenberg; Robert D Langer; John Bergan; Beatrice A Golomb
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

7.  Biochemical assay of collagen and elastin in the normal and varicose vein wall.

Authors:  M Venturi; L Bonavina; F Annoni; L Colombo; C Butera; A Peracchia; E Mussini
Journal:  J Surg Res       Date:  1996-01       Impact factor: 2.192

8.  Serum from Varicose Patients Induces Senescence-Related Dysfunction of Vascular Endothelium Generating Local and Systemic Proinflammatory Conditions.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Krzysztof Aniukiewicz; Patrycja Sosińska; Zbigniew Krasiński; Andrzej Tykarski; Krzysztof Książek
Journal:  Oxid Med Cell Longev       Date:  2016-11-23       Impact factor: 6.543

9.  Pulmonary hypertension in chronic lung disease and hypoxia.

Authors:  Steven D Nathan; Joan A Barbera; Sean P Gaine; Sergio Harari; Fernando J Martinez; Horst Olschewski; Karen M Olsson; Andrew J Peacock; Joanna Pepke-Zaba; Steeve Provencher; Norbert Weissmann; Werner Seeger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

10.  A new, rapid and reproducible method to obtain high quality endothelium in vitro.

Authors:  Nuria Jiménez; Vincent J D Krouwer; Jan A Post
Journal:  Cytotechnology       Date:  2012-05-10       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.